VISIONARY-MS Long-Term Extension Results: A Multi-Centre, Open-Label Long-Term Extension Study of CNM-Au8 in Patients with Stable Relapsing Multiple Sclerosis (RMS) on top of background disease modifying therapy (DMT)

Authors
Category Primary study
ConferenceThe 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Year 2024
This article has no abstract
Epistemonikos ID: 24537ba2f8886aeb5658cb252d9ae16b9f83fb08
First added on: Apr 04, 2026